Discussion  by unknown
Acquired Cardiovascular Disease Geisb€usch et al
A
C
D5. CoadyMA, Rizzo JA, Hammond GL,Mandapati D, Darr U, Kopf GS, et al.What
is the appropriate size criterion for resection of thoracic aortic aneurysms?
J Thorac Cardiovasc Surg. 1997;113:476-91.
6. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al.
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for
the diagnosis and management of patients with thoracic aortic disease. A Report
of the American College of Cardiology Foundation/American Heart Association
Task Force on Practice Guidelines, American Association for Thoracic Surgery,
American College of Radiology, American Stroke Association, Society of
Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and
Interventions, Society of Interventional Radiology, Society of Thoracic
Surgeons, and Society for Vascular Medicine. J Am Coll Cardiol. 2010;55:
e27-129.
7. Koullias GJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA.
Increased tissue microarray matrix metalloproteinase expression favors
proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg.
2004;78:2106-11.
8. Coady MA, Rizzo JA, Hammond GL, Kopf GS, Elefteriades JA. Surgical inter-
vention criteria for thoracic aortic aneurysms: a study of growth rates and com-
plications. Ann Thorac Surg. 1999;67:1922-6; discussion 53-8.
9. Hirose Y, Hamada S, Takamiya M, Imakita S, Naito H, Nishimura T.
Aortic aneurysms: growth rates measured with CT. Radiology. 1992;185:
249-52.
10. Masuda Y, Takanashi K, Takasu J, Morooka N, Inagaki Y. Expansion rate of
thoracic aortic aneurysms and influencing factors. Chest. 1992;102:461-6.
11. Dapunt OE, Galla JD, Sadeghi AM, Lansman SL, Mezrow CK, de Asla RA, et al.
The natural history of thoracic aortic aneurysms. J Thorac Cardiovasc Surg.
1994;107:1323-33.
12. Rizzo JA, Darr U, Fischer M, Johnson KM, Finkle JK, Gusberg RJ, et al. Multi-
modality serial follow-up of thoracic aortic aneurysms. Int J Angiol. 1997;6:
153-6.
13. Elefteriades JA, Farkas EA. Thoracic aortic aneurysm clinically pertinent contro-
versies and uncertainties. J Am Coll Cardiol. 2010;55:841-57.
14. Li JK. Comparative cardiac mechanics: Laplace’s Law. J Theor Biol. 1986;118:
339-43.
15. Lindholt JS, Sorensen HT, Michel JB, Thomsen HF, Henneberg EW. Low-dose
aspirin may prevent growth and later surgical repair of medium-sized abdominal
aortic aneurysms. Vasc Endovasc Surg. 2008;42:329-34.Discussion
Dr Michael Fischbein (Stanford, Calif). Dr Griepp and his
research laboratory have been leaders in thoracic aortic surgery
and contributed so much both clinically and scientifically.
I have 3 questions. First, any given increase in the AA volume
can be secondary to (1) an increase in the maximum dimension
or (2) elongation of the aorta with no change in the maximum74 The Journal of Thoracic and Cardiovascular Surgedimension. Do you think these 2 situations have the same risk of
rupture?
Dr Geisbuesch. No. We do not think the risk of rupture is the
same. We know that wall tension increases with increased diam-
eter, so we believe that a short, fat aorta is more likely to rupture
than a long slim one.
Dr Fischbein. Second, tell us how you are using aortic volume
measurements at Mount Sinai. Are you using a combination of
both maximum dimension and volume change, and what exact vol-
ume change or rate of volume change are you using to determine if
someone should then proceed to surgery?
Dr Geisbuesch. The decision whether or not to operate on a
patient can of course never be based on a single measurement,
so at Mount Sinai we look at family history of rupture or dissec-
tion and other risk factors, as well as volume measurements in
combination with maximum dimension. In addition, we can
look at the ratio of AA volume to total aortic volume. If we
see a significant increase in volume in combination with an in-
crease in maximum diameter, depending on these other factors,
this would then lead to the decision to a short follow-up or to op-
erate on the patient electively.
The advantage of the volumemeasurement in this context is that
because it is an objective, reproducible measurement, it reliably
ascertains whether a change has really occurred and can pinpoint
the location of an enlargement, if present. In the event that no
change in volume is documented, we can be more confident than
with diameter measurements in reassuring the patient that no
growth has occurred, and that surgery is not needed.
Dr Fischbein. Third, can this program measuring volume
change be easily used universally? Can everyone adopt this new
format?
Dr Geisbuesch. Yes. We are convinced that volume measure-
ments can be performed at other institutions. As with every new
technique, there is certainly a learning curve to obtain accurate
measurements and achieve reliability, but from our experience
we can only say that if the technician goes back and repeats the
measurements, he/she gets the same results. The key to this is con-
sistency in how the CT scans are performed and the measurements
are undertaken. Once consistency has been achieved, I think CT
volume measurements are far more objective and reproducible
than measurements of diameter at a single level.ry c January 2014
